Norges Bank
ENZN

Norges Bank’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Norges Bank’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-57,463
Closed -$115K – 2100
2013
Q2 		$115K Buy
+57,463
New +$168K ﹤0.01% 2100

Other funds holding ENZN

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Norges Bank's ENZN Position: Q3 2013 in Review

Norges Bank sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q3 2013, closing a stake of 57,463 shares — an estimated $115K sold.

Norges Bank first reported a position in ENZN in Q2 2013 and held it in 1 quarter. The position peaked at $115K in Q2 2013. 82 funds tracked by Wall St. Rank hold ENZN as of Q3 2013.

  • Norges Bank reported no remaining ENZON PHARMACEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • Norges Bank sold 57,463 ENZON PHARMACEUTICALS INC shares in Q3 2013, an estimated $115K.
  • Norges Bank first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • Norges Bank's ENZON PHARMACEUTICALS INC position peaked at $115K in Q2 2013.
  • 82 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q3 2013.

Based on Norges Bank's 13F filing for Q3 2013, filed 12 Nov 2013.